GHRH Analog Peptide
Tesamorelin Research Peptide
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH) consisting of the full 44-amino-acid GHRH sequence linked to a trans-3-hexenoic acid moiety. It is supplied as a lyophilized powder for laboratory research applications.
Compound identity
- Name
- Tesamorelin
- Class
- GHRH Analog Peptide
- CAS number
- 218949-48-5
- Molecular formula
- C221H366N72O67S
- Also known as
- TH9507, EGRIFTA (drug name)
Research context
Tesamorelin (TH9507, CAS 218949-48-5) is a GHRH analog that has been studied in preclinical and clinical research contexts. As a research reagent it is examined for its receptor-binding pharmacology at the GHRH receptor in in-vitro systems.
A version of tesamorelin (EGRIFTA) has received specific FDA approval for a narrow HIV-related indication; the research compound supplied here is for in-vitro laboratory use only and is not the pharmaceutical product. The scientific literature on GHRH analogs characterizes their receptor specificity and signaling in laboratory models.
DMV Research supplies Tesamorelin with a per-batch third-party Certificate of Analysis confirming identity and purity for research use.
Frequently asked questions
What is Tesamorelin?+
Tesamorelin is a synthetic GHRH analog consisting of the full 44-amino-acid GHRH(1-44) sequence with a trans-3-hexenoic acid modification at the N-terminus. CAS 218949-48-5. Used as a research reference compound.
How does Tesamorelin differ from other GHRH analogs?+
Tesamorelin contains the complete GHRH(1-44) sequence, whereas other analogs such as CJC-1295 are based on shorter fragments. The different sequences result in distinct receptor-binding profiles studied in preclinical research.
Is Tesamorelin approved for human use?+
A pharmaceutical version is approved for a specific HIV-related indication only. The research compound supplied by DMV Research is for laboratory use only and is not the pharmaceutical product.
What purity is the Tesamorelin research peptide?+
Each batch is independently tested to 99%+ purity by third-party laboratories, with a Certificate of Analysis available per batch.
Research use only
All products are intended for laboratory and research use only (RUO) and are not for human consumption, ingestion, or any in-vivo use.
The statements on this page have not been evaluated by the FDA. Tesamorelin is not intended to diagnose, treat, cure, or prevent any disease. Content is provided for laboratory research reference only.